Gastroesophageal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastroesophageal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: A Study of a Personalized Neoantigen Cancer Vaccine [Phase 1, Phase 2]
Clinical trial update for a personalized neoantigen cancer vaccine completed across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression [Phase 2]
Phase 2 pilot study assessing personalized antibodies for metastatic gastro-esophageal adenocarcinoma (biologics beyond progression).
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating FOLFOX alone or with AMG 102 or panitumumab as first-line treatment for advanced gastroesophageal adenocarcinoma; s…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma [Phase 1]
Phase 1 trial of MLN1117 in combination with docetaxel, paclitaxel, and other investigational anticancer agents in advanced/metastatic gastr…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Phase 2]
Phase II trial of cabazitaxel for refractory metastatic gastric adenocarcinoma and gastroesophageal adenocarcinoma completed; results were p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 trial results update for alisertib in adults with advanced nonhematological malignancies, including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating the combination of docetaxel, oxaliplatin, and S-1 in potentially operable gastric or gastroesophageal adenocarci…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating panitumumab with paclitaxel, carboplatin and 5-FU in potentially resectable gastroesophageal adenocarcinom…